癌症患者急性偶然发现脑微梗死与后续缺血性卒中的关联:一项基于人群的研究
该回顾性队列研究利用以色列Clalit健康服务记录,纳入2014年1月至2020年4月期间接受脑MRI的肺癌、乳腺癌、胰腺癌或结肠癌成人患者,共1618例,其中59例(3.6%)至少一次脑MRI发现急性偶然性脑微梗死。多变量分析显示,急性偶然性脑微梗死与卒中或短暂性脑缺血发作风险升高相关(HR 2.97,95%CI 1.08-8.18,p=0.035),并与死亡率升高相关(HR 2.76,95%CI 2.06-3.71,p<0.001),与颅内出血无关联。
要点
- 癌症患者中急性偶然性脑微梗死的检出率为3.6%(59/1618)。
- 急性偶然性脑微梗死与后续缺血性卒中或TIA风险升高相关(HR 2.97)。
- 急性偶然性脑微梗死与死亡率升高相关(HR 2.76),与颅内出血无关联。
核心结论
- 活动性癌症患者脑MRI上急性偶然性脑微梗死与近期缺血性卒中或TIA风险升高及死亡率升高相关。
- 作者认为,癌症患者中随机检测到的急性偶然性脑微梗死可能指导原发性脑血管风险预防和病因学检查。
研究设计与样本
- 回顾性队列研究,使用以色列Clalit健康服务记录。
- 纳入2014年1月至2020年4月期间接受脑MRI的肺癌、乳腺癌、胰腺癌或结肠癌成人患者,MRI时间在癌症诊断前1年至诊断后1年内。
- 共纳入1618例患者,其中59例(3.6%)至少一次脑MRI发现急性偶然性脑微梗死。
- 主要结局为缺血性卒中或TIA(使用国际疾病分类第九版代码),次要结局为颅内出血和死亡率。
- 随访从首次MRI至主要结局、死亡或随访结束(2023年1月)。
主要发现
- 急性偶然性脑微梗死至卒中或TIA的中位时间(四分位距)为26天(14-84)。
- 多变量分析显示,急性偶然性脑微梗死患者卒中或TIA风险较无微梗死患者升高(HR 2.97,95%CI 1.08-8.18,p=0.035)。
- 多变量分析显示,急性偶然性脑微梗死与死亡率升高相关(HR 2.76,95%CI 2.06-3.71,p<0.001)。
- 急性偶然性脑微梗死与颅内出血无关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Incidental diffuse-weighted imaging (DWI)-positive subcortical and cortical lesions, or acute incidental cerebral microinfarcts (CMIs), are a common type of brain ischemia, which can be detected on magnetic resonance DWI for approximately 2 weeks after occurrence. Acute incidental CMI was found to be more common in patients with cancer. Whether acute incidental CMI predicts future ischemic stroke is still unknown. We aimed to examine the association between acute incidental CMI in patients with cancer and subsequent ischemic stroke or transient ischemic attack (TIA). METHODS: This is a retrospective cohort study. We used Clalit Health Services records, representing over half of the Israeli population, to identify adults with lung, breast, pancreatic, or colon cancer who underwent brain MRI between January 2014 and April 2020. We included patients who underwent scan between 1 year before cancer diagnosis and 1 year after diagnosis. Primary outcome was ischemic stroke or TIA using International Classification of Diseases, Ninth Revision codes. Secondary outcomes were intracranial hemorrhage (ICH) and mortality. Records were followed from first MRI until primary outcome, death, or end of follow-up (January 2023). Cox proportional hazards models were used to calculate hazard ratio (HR) for patients with and without acute incidental CMI, as a time-dependent covariate. RESULTS: The study cohort included 1,618 patients with cancer, among whom, 59 (3.6%) had acute incidental CMI on at least 1 brain MRI. The median (interquartile range) time from acute incidental CMI to stroke or TIA was 26 days (14-84). On multivariable analysis, patients with acute incidental CMI had a higher stroke or TIA risk (HR 2.97, 95% CI 1.08-8.18, p = 0.035) compared with their non-CMI counterparts. Acute incidental CMIs were also associated with mortality after multivariable analysis (HR 2.76, 95% CI 2.06-3.71, p < 0.001); no association with ICH was found. DISCUSSION: Acute incidental CMI on brain MRI in patients with active cancer is associated with an increased risk of near-future ischemic stroke or TIA and mortality. This finding might suggest that randomly detected acute incidental CMI in patients with cancer may guide primary cerebrovascular risk prevention and etiologic workup.
引用
- Naftali J, Barnea R, Leader A, et al. Association of Acute Incidental Cerebral Microinfarcts With Subsequent Ischemic Stroke in Patients With Cancer: A Population-Based Study. Neurology. 2024. PMID: 38981073. doi:10.1212/WNL.0000000000209655
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。